COVID-19 pandemic in Afghanistan: overview, response, and impacts

Progression and timeline

Initial cases were concentrated in border provinces, especially where cross-border movement with neighboring countries was frequent. Over months the country experienced multiple waves typical of the global pattern, driven by importation of cases, community transmission, and variable implementation of control measures. Testing capacity, case reporting, and surveillance expanded slowly with support from international agencies.

Public health response

Authorities and health partners employed conventional epidemic tools: case isolation, contact tracing, testing scale-up, quarantine of returnees, and public information campaigns. Measures also included temporary closures of schools and markets, limits on gatherings, and targeted lockdowns. Vaccination campaigns later became a core element of the response, using doses provided through global mechanisms and bilateral donations to prioritize frontline workers and vulnerable groups.

Challenges and vulnerabilities

• Fragile health system with limited critical care capacity and uneven access to services across provinces.
• Large numbers of internally displaced people and returning migrants increased transmission risks and complicated tracking.
• Security issues and governance transitions affected delivery of health services in some areas.
• Testing shortages, stigma, and underreporting hampered accurate measurement of the epidemic's full extent.

Social and economic impacts

The pandemic disrupted education, routine vaccination and disease-control programs, trade, and livelihoods. Humanitarian operations had to adapt to deliver food, shelter, and health assistance while minimizing infection risk. Economic contraction and mobility restrictions added pressure on households already dependent on informal work and aid.

Notable facts and lessons

The Afghan experience highlighted how epidemics compound existing crises. International coordination helped scale testing, treatment, and vaccination, but long-term resilience depends on strengthening primary health care, surveillance, and social protections. Continued attention to equitable vaccine access and support for displaced and hard-to-reach communities remains central to recovery.